Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K161446
    Manufacturer
    Date Cleared
    2016-09-27

    (125 days)

    Product Code
    Regulation Number
    882.5320
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K043133

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Biopor® Porous Polyethylene Implants in sheet configurations are intended for the augmentation or reconstruction of the craniofacial skeleton, including the cranial skeleton, orbit, nasal bones and the zygoma.

    Device Description

    Biopor® Porous Polyethylene Implants are manufactured of porous high-density polyethylene (PPE), a biomaterial that is contoured or carved to suit the anatomical and functional requirements of the patient. The implants are manufactured with the option of a coating with a water-soluble alkylene oxide copolymer blend (AOC). Biopor® Porous Polyethylene Implants are provided STERILE and must not be resterilized.

    AI/ML Overview

    The provided FDA 510(k) summary document for the Biopor Porous Polyethylene Implants does not describe a study involving an AI/Machine Learning device or a diagnostic device where the acceptance criteria would be related to performance metrics like sensitivity, specificity, or reader improvement.

    Instead, this document is for a physical medical implant (Preformed Alterable Cranioplasty Plate). The "performance testing" described in the document refers to biocompatibility and physical/mechanical properties of the implant, not diagnostic accuracy or AI algorithm performance.

    Therefore, I cannot provide the information requested in your prompt because it pertains to the performance evaluation of an AI/ML or diagnostic device, which is not what this document describes.

    However, I can extract the "acceptance criteria" and "reported device performance" as they relate to the physical and biological characteristics of the implant described in this document.

    Here's a breakdown of the acceptance criteria and the study that proves the device meets them, based on the provided document:

    The "acceptance criteria" for this device are related to its material properties, biocompatibility, and physical performance as an implant. The "study" refers to a series of tests conducted to ensure safety and function.

    1. Table of Acceptance Criteria and Reported Device Performance

    TestAcceptance Criteria (Implied/Stated)Reported Device Performance
    Biocompatibility Tests
    Cytotoxicity Study Using the End-Point TitrationNo cytotoxicity detectedThe extract tested negative after 24, 48 and 72 hours. No cytotoxicity detected.
    Murine Local Lymph Node Assay (LLNA)Not considered sensitizingUnder the conditions of the study, the material was not considered sensitizing to the mouse.
    ISO Modified Intracutaneous SolutionNegligible irritationThe primary irritation index characterization for the test article was negligible.
    USP and ISO Modified Systemic ToxicityNo evidence of systemic toxicityThere was no evidence of systemic toxicity.
    ISO Muscle ImplantationClassified as a non-irritantAfter 2 weeks, the test article was classified as a non-irritant.
    Genotoxicity: Mouse Bone Marrow MicronucleusNo evidence of cellular toxicityThe coating showed no evidence of cellular toxicity.
    Genotoxicity: Bacterial Reverse MutationNo evidence of cellular toxicityThe coating showed no evidence of cellular toxicity.
    Genotoxicity: In Vitro Chromosomal AberrationNo evidence of cellular toxicityThe coating showed no evidence of cellular toxicity.
    Bone Implantation Study in the Femur of the RabbitNormal healing and absorption of test article (where applicable)The test article was absorbed and all sites were healing normally.
    AOC Polymer HemolysisNon-hemolyticThe test article was non-hemolytic.
    PPE Post-irradiation CytotoxicityNon-cytotoxicThe test articles were non-cytotoxic.
    ISO Intramuscular Implantation AOC Coated & Uncoated PPEFibrovascular ingrowth indicates tissue integration/compatibility.Fibrovascular ingrowth occurred into coated and uncoated implants.
    Physical/Mechanical Tests
    Suture Pull-out of AOC-Coated Biopor Porous Polyethylene ImplantMeet acceptance criteria (specific numerical criteria not detailed in this summary, but implied by "met")The test articles met acceptance criteria.
    Biopor Sheet Performance QualificationMeet acceptance criteria for flexibility (specific criteria not detailed)The test articles met acceptance criteria.
    Porosity Characterization of Porous Polyethylene ImplantsPore size greater than 40 µmThe test articles met acceptance criteria (implying pore size was > 40 µm).
    Endotoxin Specification
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1